Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development (vol 19, pg 2313, 2013)

被引：0
|
作者：
Bertram [1 ]
Hellman, Kiki B. [1 ]
机构：
[1] Hellman Grp LLC, Clarksburg, MD USA
来源：
TISSUE ENGINEERING PART A | 2013年 / 19卷 / 23-24期
关键词：
D O I：
10.1089/ten.tea.2013.0536.cxn
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：2735 / 2735
页数：1
相关论文
共 11 条
  • [1] Enhancing Tissue Engineering/Regenerative Medical Product Commercialization: The Role of Science in Regulatory Decision Making for Tissue Engineering/Regenerative Medicine Product Development
    Bertram, Timothy A.
    Johnson, Peter C.
    Tawil, Bill
    Van Dyke, Mark
    Hellman, Kiki B.
    [J]. TISSUE ENGINEERING PART A, 2013, 19 (21-22) : 2313 - 2313
  • [2] Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development
    Bertram, Timothy A.
    Johnson, Peter C.
    Tawil, Bill J.
    Van Dyke, Mark
    Hellman, Kiki B.
    [J]. TISSUE ENGINEERING PART A, 2015, 21 (19-20) : 2476 - 2479
  • [3] Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry
    Hellman, Kiki B.
    Johnson, Peter C.
    Bertram, Timothy A.
    Tawil, Bill
    [J]. TISSUE ENGINEERING PART A, 2011, 17 (1-2) : 1 - 3
  • [4] Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Survey of North American Academia and Industry
    Johnson, Peter C.
    Bertram, Timothy A.
    Tawil, Bill
    Hellman, Kiki B.
    [J]. TISSUE ENGINEERING PART A, 2011, 17 (1-2) : 5 - 15
  • [5] Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Pilot Survey of Governmental Funding Agencies and the Financial Industry
    Bertram, Timothy A.
    Tentoff, Edward
    Johnson, Peter C.
    Tawil, Bill
    Van Dyke, Mark
    Hellman, Kiki B.
    [J]. TISSUE ENGINEERING PART A, 2012, 18 (21-22) : 2187 - 2194
  • [6] Clinical Translation of Cell Therapy, Tissue Engineering, and Regenerative Medicine Product in Malaysia and Its Regulatory Policy
    Idrus, Ruszymah Bt Hj
    Abas, Arpah
    Ab Rahim, Fazillahnor
    Bin Saim, Aminuddin
    [J]. TISSUE ENGINEERING PART A, 2015, 21 (23-24) : 2812 - 2816
  • [7] Tissue Engineering and Regenerative Medicine: Role of Toxicologic Pathologists for an Emerging Medical Technology
    Jayo, Manuel J.
    Watson, David D.
    Wagner, Belinda J.
    Bertram, Timothy A.
    [J]. TOXICOLOGIC PATHOLOGY, 2008, 36 (01) : 92 - 96
  • [8] The Government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics
    Smith, DS
    [J]. PERIODONTOLOGY 2000, 2006, 41 : 16 - 29
  • [9] Biofabrication offers future hope for tackling various obstacles and challenges in tissue engineering and regenerative medicine: A Perspective (vol 5, pg 153, 2019)
    Mir, T. A.
    Nakamura, M.
    Iwanaga, S.
    [J]. INTERNATIONAL JOURNAL OF BIOPRINTING, 2020, 6 (04) : 130 - 130
  • [10] Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering
    Pant, Tarun
    Juric, Matea
    Bosnjak, Zeljko J.
    Dhanasekaran, Anuradha
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
12